UPDATE 2-U.S. approves Fresenius purchase of NxStage [Reuters]
NXSTAGE MEDICAL (NXTM)
Last nxstage medical earnings: 8/7 03:14 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.nxstage.com/investor-overview
Company Research
Source: Reuters
U.S. approves Fresenius purchase of NxStage with conditions WASHINGTON (Reuters) - The U.S. Federal Trade Commission has given Fresenius Medical Care AG and NxStage Medical Inc antitrust approval for their merger with conditions, the agency said on Tuesday. To win approval for the $2 billion deal, the companies agreed to sell NxStage’s bloodline tubing set business, the agency said. Fresenius and NxStage together dominate the market for the single-use plastic tubes used during dialysis, the agency said. The five FTC commissioners split along party lines in voting on whether to approve the merger. The three Republicans, Joseph Simons, Noah Phillips and Christine Wilson voted “yes” while Democrats Rohit Chopra and Rebecca Slaughter dissented. Reporting by Diane Bartz; Editing by James Dalgleish and Susan Thomas Our Standards: The Thomson Reuters Trust Principles.
Show less
Read more
Impact Snapshot
Event Time:
NXTM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NXTM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NXTM alerts
High impacting NXSTAGE MEDICAL news events
Weekly update
A roundup of the hottest topics